Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study The results generally indicate that ...
In a world where diversity in cognitive and sensory experiences is becoming increasingly recognized, the importance of giving children—whether neurodivergent or neurotypical—effective adaptive tools ...
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study Longitudinal trajectories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results